Financial Toxicity Linked to QOL After Breast Cancer Surgery
Strongest correlation seen for BREAST-Q psychosocial well-being, with 0.89 change per unit change in financial toxicity score.
Strongest correlation seen for BREAST-Q psychosocial well-being, with 0.89 change per unit change in financial toxicity score.
Development of prognostic tool identified a range of variables that combine to predict recurrence-free and overall survival in patients with early-stage triple-negative breast cancer.
For women with early breast cancer treated with anthracyclines, statin exposure is associated with a lower risk for hospital presentation for heart failure.
For screen-detected, younger-diagnosis breast cancers, best-fitting models include new measures based on brightness, texture.
An analysis of patient outcomes revealed links between depression and HRQOL in patients with their informal caregivers’ level of health literacy.
Local recurrence increased but overall survival at 10 years similar with omission of RT in older women with HR+ breast cancer.
Under-recognition of at least one of four symptoms occurred at least once for 53.2 percent of patients reporting symptoms.
Literature review highlights barriers and aids to breastfeeding for breast cancer survivors.
[Breast Cancer: Targets and Therapy] This review focuses on alpelisib, a PI3K inhibitor, approved for the treatment of HR+/HER2 negative metastatic breast cancer in patients with a PIK3CA mutation who have received prior endocrine therapy.
The effect of fertility preservation on reproductive outcomes for breast cancer survivors after their treatment is completed was investigated in this Swedish study.